查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
組織檢驗·細胞檢驗的全球市場-成長，未來展望，競爭分析(2022年～2030年)
市場調查報告書
商品編碼
1149152

組織檢驗·細胞檢驗的全球市場-成長，未來展望，競爭分析(2022年～2030年)

Histology and Cytology Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

全球組織檢驗·細胞檢驗的市場規模在2022年～2030年的預測期間內預計將以13.6％的年複合成長率增長。公共衛生意識的提升，細胞檢驗的需求提升，組織診斷套件的技術進步，針對慢性疾病診斷的組織診斷套件的開發·商業化的主要企業的策略性聯盟，促進了組織檢驗·細胞檢驗市場的成長。

本報告提供全球組織檢驗·細胞檢驗市場相關調查分析，提供商務展望，市場動態，市場分析，企業簡介等系統性資訊。

目錄

第1章 序文

  • 報告的說明
    • 報告的目的
    • 對象者
    • 主要的產品
  • 市場區隔
  • 調查手法
    • 階段Ⅰ-2次調查
    • 階段Ⅱ-1次調查
    • 階段Ⅲ-專家的審查
    • 假設
    • 所採用的方法

第2章 摘要整理

  • 市場概述:全球組織檢驗·細胞檢驗市場
  • 全球組織檢驗·細胞檢驗市場(100萬美元)(2021年):檢查別
  • 全球組織檢驗·細胞檢驗市場(100萬美元):各地區
  • COVID-19影響
  • 富有魅力的投資提案(2021年):各地區
  • 競爭分析
    • 主要的組織檢驗·細胞檢驗市場供應商的市場定位
    • 組織檢驗·細胞檢驗市場供應商採用的策略
    • 主要的產業策略

第3章 組織檢驗·細胞檢驗市場:商務展望和市場動態

  • 簡介
  • 全球組織檢驗·細胞檢驗市場金額(100萬美元)(2020年～2030年)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素與阻礙因素的影響分析
  • Seesaw分析
  • 波特的五力分析
    • 供應商的力量
    • 買主的力量
    • 替代品的威脅
    • 新加入廠商業者的威脅
    • 競爭企業間的敵對關係
  • PESTEL分析
    • 政治
    • 經濟
    • 技術性
    • 法律
    • 社會

第4章 組織檢驗·細胞檢驗市場，美金(100萬)(2020年～2030年):檢查別

  • 市場概要
  • 成長和收益分析:2021年和2030年的比較
  • 市場區隔
    • 細胞檢驗
    • 組織檢驗

第5章 北美的組織檢驗·細胞檢驗市場，美金(100萬)(2020年～2030年)

第6章 英國及歐洲聯盟的組織檢驗·細胞檢驗市場，美金(100萬)(2020年～2030年)

第7章 亞太地區的組織檢驗·細胞檢驗市場，美金(100萬)(2020年～2030年)

第8章 南美的組織檢驗·細胞檢驗市場，美金(100萬)(2020年～2030年)

第9章 中東及非洲的組織檢驗·細胞檢驗市場，美金(100萬)(2020年～2030年)

第10章 企業簡介

  • Abbott Laboratories, Inc.
  • Becton Dickinson and Company
  • Danaher Corporation
  • F.Hoffman-La Roche Ltd.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Life Technologies Corporation
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Trivitron Healthcare
Product Code: 138682-08-22

Industry Outlook

The histology and cytology market is annual growth rate (CAGR) of 13.6% during the forecast period from 2022 to 2030. As per the research citings provided by World Health Organization (WHO) the global burden of cancer is approximately 18.1 million new cases and with 9.6 million deaths in 2022. The major factors responsible for the occurrence of chronic disease are increasing consumption of tobacco, alcohol, junk food, sedentary lifestyle and stress. Researchers are of the view that in the light of in the era of modern technology, utilization of sophisticated technology pertaining to histology and cytology examinations will help in promoting early diagnosis and curtailing morbidity associated with chronic ailments. Rising public health awareness will further bolster the histology and cytology market growth during the forecast period from 2022 to 2030.

Increasing demand for cell screening and inherent features such as low cost, high sensitivity and adequate specificity drive the cytology examination market growth

Cytology examination are dominating the type of examination segment for histology and cytology market. The growth factors creating a positive impact in the cytology examination market growth are increasing demand for cell screening in breast and cervical cancer patients. Inherent features such as low cost, high sensitivity and adequate specificity associated with cytology examination procedure further fortify its market growth. Histology examination procedures will be growing at a rapid pace on account of technological advancement in tissue diagnostic kits and strategic collaboration among major players for further development and commercialization of histology examination procedures in diagnosis of chronic ailments.

Significant rise in cancer diagnosis and increasing public health awareness drive the market growth in North America

North America currently holds 35% market share and is the leading regional market for histology and cytology market. The major factors controlling its market growth are significant rise in cancer diagnosis and increasing public health awareness. As per the statistics provided by Center for Disease Control and Prevention (CDC) in 2021, the number of adults been diagnosed with cancer were 23.2 million which represents 9.4% of the total population. Existence of key players such as Abbott Laboratories, Inc., Hologic, Inc., Thermo Fisher Scientific, Inc. etc. provide a positive impetus to the histology and cytology market growth in North America region. Europe holds 30% market share on account of rising prevalence of cancer and supportive environment provided by European Medical Agency (EMA) for histology and cytology diagnostic procedures. Asia Pacific is accountable for 16% share and is keen to register outstanding growth owing to rampant growth in healthcare infrastructure development and adoption to sophisticated diagnostic technology pertaining to cytology and histology studies.

Biotechnology companies specializing in histology and cytology market are: Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, Sysmex Corporation, F.Hoffman-La Roche Ltd., Trivitron Healthcare, Hologic, Inc., Koninklijke Philips N.V. and Life Technologies Corporation.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Histology and Cytology market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Histology and Cytology market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Examination

  • Cytology
    • Cervical Cancer
    • Breast Cancer
    • Other Cancers
  • Histology

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Histology and Cytology market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Histology and Cytology market?
  • Which is the largest regional market for Histology and Cytology market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Histology and Cytology market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Histology and Cytology market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Histology and Cytology Market
  • 2.2. Global Histology and Cytology Market, By Examination, 2021 (US$ Million)
  • 2.3. Global Histology and Cytology Market, By Geography, 2021 (US$ Million)
  • 2.4. Impact of Covid 19
  • 2.5. Attractive Investment Proposition by Geography, 2021
  • 2.6. Competitive Analysis
    • 2.6.1. Market Positioning of Key Histology and Cytology Market Vendors
    • 2.6.2. Strategies Adopted by Histology and Cytology Market Vendors
    • 2.6.3. Key Industry Strategies

3. Histology and Cytology Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Histology and Cytology Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Histology and Cytology Market: By Examination, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Cytology
      • 4.3.1.1. Cervical Cancer
      • 4.3.1.2. Breast Cancer
      • 4.3.1.3. Other Cancers
    • 4.3.2. Histology

5. North America Histology and Cytology Market, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Histology and Cytology Market: By Examination, 2020-2030, USD (Million)
  • 5.3.Histology and Cytology Market: By Region, 2020-2030, USD (Million)
    • 5.3.1.North America
      • 5.3.1.1. U.S.
      • 5.3.1.2. Canada
      • 5.3.1.3. Rest of North America

6. UK and European Union Histology and Cytology Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Histology and Cytology Market: By Examination, 2020-2030, USD (Million)
  • 6.3.Histology and Cytology Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.UK and European Union
      • 6.3.1.1. UK
      • 6.3.1.2. Germany
      • 6.3.1.3. Spain
      • 6.3.1.4. Italy
      • 6.3.1.5. France
      • 6.3.1.6. Rest of Europe

7. Asia Pacific Histology and Cytology Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Histology and Cytology Market: By Examination, 2020-2030, USD (Million)
  • 7.3.Histology and Cytology Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.Asia Pacific
      • 7.3.1.1. China
      • 7.3.1.2. Japan
      • 7.3.1.3. India
      • 7.3.1.4. Australia
      • 7.3.1.5. South Korea
      • 7.3.1.6. Rest of Asia Pacific

8. Latin America Histology and Cytology Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Histology and Cytology Market: By Examination, 2020-2030, USD (Million)
  • 8.3.Histology and Cytology Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Latin America
      • 8.3.1.1. Brazil
      • 8.3.1.2. Mexico
      • 8.3.1.3. Rest of Latin America

9. Middle East and Africa Histology and Cytology Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Histology and Cytology Market: By Examination, 2020-2030, USD (Million)
  • 9.3.Histology and Cytology Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Middle East and Africa
      • 9.3.1.1. GCC
      • 9.3.1.2. Africa
      • 9.3.1.3. Rest of Middle East and Africa

10. Company Profile

  • 10.1. Abbott Laboratories, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Portfolio
    • 10.1.4. Strategic Initiatives
  • 10.2. Becton Dickinson and Company
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Portfolio
    • 10.2.4. Strategic Initiatives
  • 10.3. Danaher Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Portfolio
    • 10.3.4. Strategic Initiatives
  • 10.4. F.Hoffman-La Roche Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Portfolio
    • 10.4.4. Strategic Initiatives
  • 10.5. Hologic, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Portfolio
    • 10.5.4. Strategic Initiatives
  • 10.6. Koninklijke Philips N.V.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Portfolio
    • 10.6.4. Strategic Initiatives
  • 10.7. Life Technologies Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Portfolio
    • 10.7.4. Strategic Initiatives
  • 10.8. Sysmex Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Portfolio
    • 10.8.4. Strategic Initiatives
  • 10.9. Thermo Fisher Scientific, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Portfolio
    • 10.9.4. Strategic Initiatives
  • 10.10. Trivitron Healthcare
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Portfolio
    • 10.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Histology and Cytology Market By Examination, 2020-2030, USD (Million)
  • TABLE 2 Global Histology and Cytology Market By Cytology, 2020-2030, USD (Million)
  • TABLE 3 North America Histology and Cytology Market By Examination, 2020-2030, USD (Million)
  • TABLE 4 North America Histology and Cytology Market By Cytology, 2020-2030, USD (Million)
  • TABLE 5 UK and European Union Histology and Cytology Market By Examination, 2020-2030, USD (Million)
  • TABLE 6 UK and European Union Histology and Cytology Market By Cytology, 2020-2030, USD (Million)
  • TABLE 7 Asia Pacific Histology and Cytology Market By Examination, 2020-2030, USD (Million)
  • TABLE 8 Asia Pacific Histology and Cytology Market By Cytology, 2020-2030, USD (Million)
  • TABLE 9 Latin America Histology and Cytology Market By Examination, 2020-2030, USD (Million)
  • TABLE 10 Latin America Histology and Cytology Market By Cytology, 2020-2030, USD (Million)
  • TABLE 11 Middle East and Africa Histology and Cytology Market By Examination, 2020-2030, USD (Million)
  • TABLE 12 Middle East and Africa Histology and Cytology Market By Cytology, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Histology and Cytology Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Histology and Cytology Market: Quality Assurance
  • FIG. 5 Global Histology and Cytology Market, By Examination, 2021
  • FIG. 6 Global Histology and Cytology Market, By Geography, 2021
  • FIG. 7 Global Histology and Cytology Market, By Examination, 2021 Vs 2030, %
  • FIG. 8 U.S. Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 9 Canada Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 10 Rest of North America Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 11 UK Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 12 Germany Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 13 Spain Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 14 Italy Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 15 France Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 16 Rest of Europe Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 17 China Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 18 Japan Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 19 India Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 20 Australia Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 21 South Korea Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 22 Rest of Asia Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 23 Brazil Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 24 Mexico Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Latin America Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 26 GCC Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 27 Africa Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Middle East and Africa Histology and Cytology Market (US$ Million), 2020 - 2030